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Production and hosting by ElsevierAbstract The arterial switch operation is the procedure of choice for patients with isolated transpo-
sition of the great arteries or those with associated atrial and/or ventricular septal defects. After the
development of pulmonary arterial hypertension, the surgical options for patients with a late presen-
tation include either retraining the left ventricle by pulmonary artery banding followed by an arterial
switch operation or palliative atrial or arterial switch, with or without medical management of pul-
monary hypertension. We present a case with D-transposition of the great arteries with ventricular
septal defects and irreversible pulmonary arterial hypertension who improved after a palliative atrial
switch operation.
ª 2009 King Saud University. All rights reserved.1. IntroductionComplete transposition of the great arteries (D-TGA) repre-
sents approximately 5–8% of congenital cardiac malforma-
tions but accounts for 25% of deaths from congenital heart
disease in the ﬁrst year of life (Liebman et al., 1969). Survival
is highly dependent on the interplay and mixing between the
two parallel circuits and the amount of pulmonary blood ﬂow
(Maeno et al., 2000).
The prognosis for unoperated patients with TGA with
intact ventricular septum is poor. The overall mortality rate
for unoperated cases is 29% in the ﬁrst week, 52% in the
ﬁrst month, and 89% in the ﬁrst year (Galie et al., 2004).
Unoperated TGA associated with ASD and/or VSD has a
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with atrial or ventricular septal defect in addition to TGA is
9 or 22 months, respectively (Galie et al., 2004). At present,
the typical treatment is a deﬁnitive corrective procedure (the
arterial switch operation) early in infancy; with this proce-
dure, many patients reach adulthood (Wijesekera et al.,
2005) and they may have normal life expectancy.
2. Case report
We report an 8-year-old Saudi female child delivered vaginally
at home after an uneventful full-term pregnancy. At 3 months
of age, the infant was noticed to have bluish discoloration, dia-
phoresis, and excessive crying. She was diagnosed with TGA
and a VSD. An atrial septostomy was performed, and she
was referred for an arterial switch operation. Unfortunately,
the parents misunderstood (or ignored) the plan and missed
the referral and the follow-up visits. The child presented at
18 months of age with evidence of severe pulmonary arterial
hypertension (PAH) due to pulmonary vascular disease and
was declared inoperable.
She was referred to our centre at 8 years of age with severe
exertional dyspnoea and exercise intolerance (NYHA func-
tional class IV). On examination, she was physically well
developed with a weight of 16.3 kg (below the 5th percentile)
and a height of 120 cm (between the 10th and 25th percen-
tiles). She was cyanosed with marked digital clubbing. She
had physical signs consistent with right ventricular hypertro-
phy and clinical evidence of PAH. No signs of heart failure
were evident. Her resting oxygen saturation was around
60%. Her haemoglobin was 18.5 g/dl, and haematocrit was
58 L/l. Transthoracic echocardiography demonstrated atrio-
ventricular concordance, ventriculoarterial discordance and a
large perimembranous VSD as well as a patent ductus arteri-
osus with severe tricuspid insufﬁciency. After a joint medical/
surgical discussion, we considered her for a palliative atrial or
arterial switch surgery. Diagnostic cardiac catheterisation was
performed and revealed the presence of severe PAH with
suprasystemic pulmonary arterial pressures. Her pulmonary
artery saturation on room air was 91%, and the indexed
pulmonary vascular resistance was 10 Woods units m2. With
100% oxygen and inhaled nitric oxide at 20 parts per million
for 10 min, the pulmonary arterial saturation rose to 97%;
however, there was minimal change in the pulmonary vascular
resistance. The decision was to proceed to atrial switch
operation.
The patient underwent an atrial switch operation (Mus-
tard procedure) and patent ductus arteriosus ligation with
tricuspid valve repair. The VSD was not closed. The postop-
erative course was uneventful. Seventeen months post-proce-
dure, she was NYHA functional class I, her resting
saturations varied from 85% to 90%, her haemoglobin was
13.5 g/dl, and her haematocrit was 42 L/l. There were no
signs of heart failure.
Her medications included furosemide 10 mg orally twice
daily, captopril 1.5 mg orally three times daily, aspirin 50 mg
orally once daily, and sildenaﬁl 3 mg orally three times daily.
Sildenaﬁl was stopped 14 months post-operatively (to avoid
an increase in pulmonary blood ﬂow and the possible develop-
ment of heart failure). No further surgical intervention was
planned.3. Discussion
Despite advances in cardiac surgery, systemic or suprasystemic
pulmonary vascular pressure associated with congenital heart
disease remains a major problem. Recently, advanced thera-
pies for PAH have become available and are effective at reduc-
ing pulmonary vascular resistance and symptoms in patients
with near-systemic pulmonary arterial pressures. Previously,
these patients were thought to have irreversible pulmonary
vascular disease. This raises an interesting question; speciﬁ-
cally, can intra-cardiac communications previously considered
inoperable due to severe pulmonary vascular disease become
amenable to surgery after successful treatment with advanced
therapy (Dimopoulos et al., 2008)?
The Eisenmenger syndrome is at the extreme end of the
spectrum of PAH secondary to congenital heart disease. It in-
cludes all left-to-right shunts that result in signiﬁcant systemic
or near-systemic PAH with subsequent reversal of the shunt
direction. It results in a signiﬁcant increase in morbidity and
mortality and greatly affects the quality of life.
The current deﬁnition of PAH relies on the presence of a
mean pulmonary arterial pressure exceeding 25 mm Hg at rest
or 30 mm Hg during exercise and a resting pulmonary vascular
resistance above 3 Woods units (Galie et al., 2004; Rubin and
Badesch, 2005). An estimated 5–10% of all patients with
CHD, mostly those with late or no repair, have some form
of PAH (Galie et al., 2004; Engelfriet et al., 2007).
In theory, all large communications that result in pulmon-
ary over-circulation by means of a signiﬁcant left-to-right
shunt can produce progressive histologic and patho-physio-
logic abnormalities in the pulmonary vascular bed leading to
PAH. VSDs are the most common simple defects causing
PAH. An estimated 10% of all VSDs and 50% of large VSDs
have the potential to cause Eisenmenger syndrome, if not
repaired by age two (Hoffman and Rudolph, 1965).
An acute reduction in the mean pulmonary arterial pressure
of 10 mm Hgwith a resultant mean pulmonary arterial pressure
of 40 mm Hgor lesswithout a fall in cardiac output is considered
a positive vasoreactivity response. Balloon test occlusion of the
cardiac defect may provide additional information on the suit-
ability for closure and the possible post-procedural outcome.
A drop in cardiac output and/or an increase in right ventricular
ﬁlling pressures with a test balloon occlusion would suggest a
low likelihood of beneﬁt from permanent closure as well as a
higher perioperative risk (Allen et al., 2008).
Palliative can be done to reduce the hypoxia in patients with
PAH secondary to TGA/VSD. In these patients the pulmonary
arterial oxygen saturations is higher than that in the aorta
(Bernhard et al., 1976; Burkhart et al., 2004). The increase in
arterial oxygen saturation resulting from the redirection of ﬂow
provides signiﬁcant symptomatic relief and increased quality of
life in patients with severe cyanosis-related symptoms.
The goals of cardiac surgery in adult patients with CHD
and PAH are to avoid complications of Eisenmenger syn-
drome, such as addressing the right-to-left shunt, decreasing
cerebrovascular events (stroke and abscess), preventing cyano-
sis and improving exercise capacity, reducing erythrocytosis
and haemostatic complications, reducing the incidence of sys-
temic organ failure, and protecting the pulmonary circulation.
Currently, no data are available on the long-term response of
the right ventricle to closure of intra-cardiac communications
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closed, a patho-physiologic situation more similar to idio-
pathic PAH could become established, which is associated
with a much worse long-term outcome than Eisenmenger syn-
drome (Dimopoulos et al., 2008).
In 1982, Jatene described the ﬁrst successful arterial switch
operation (Jatene et al., 1982). In 1987, Senning wrote: ‘‘I
think that the arterial switch––a real anatomical correction––
will be the ‘gold standard’ in the near future and the atrial
switch will be used only for the few patients who are not suit-
able candidates for the arterial switch’’ (Bove, 1987).
The current indications for an atrial switch procedure
include:
(1) Infants with isolated TGA (with intact ventricular sep-
tum) who present after the neonatal period. The alterna-
tive approach is pulmonary artery banding to train the
left ventricle followed by arterial switch.
(2) Palliation of patients with pulmonary vascular disease
from an associated ventricular septal defect (Burkhart
et al., 2004).
(3) Patients with a congenitally corrected transposition in
whom repair includes both a venous and arterial switch
to create ventriculoarterial concordance or in patients
with associated pulmonary valve stenosis or atresia, an
atrial switch combined with a Rastelli operation
(namely, Ilbawi’s operation, also known as a ‘‘double
switch’’ or ‘‘anatomical correction’’) (Ilbawi et al.,
1990; Konstantinov and Williams, 2003).
(4) For the rare anomaly of isolated ventricular inversion,
there is atrioventricular discordance with ventriculoarte-
rial concordance (Pasquini et al., 1988). The atrial
switch operation corrects the circulation physiologically
and leaves the morphologic left ventricle supporting the
systemic circulation. In this case, the arterial switch
operation is contraindicated because of the presence of
ventriculoarterial concordance.
(5) Patients with other complex congenital lesions with
VSD, transposition haemodynamics, and severe pul-
monary vascular obstructive disease (PVOD) (Current
case) (Bernhard et al., 1976; Lindesmith et al., 1972;
Corno et al., 1987; Konstantinov et al., 2004).
In the current era, newborns with transposition have a 20-
year survival well over 95% after arterial switch operation
(Williams, 2006).
In 1972, Lindesmith et al. were the ﬁrst to report a series of
patients with TGA, VSD, and severe PVOD who underwent a
palliative atrial switch operation (PAS) (Lindesmith et al.,
1972). This operation consisted of a Mustard procedure to re-
route pulmonary and systemic venous drainage while leaving
the VSD open. The VSD was not closed because experience
indicated that closure in such patients was associated with sig-
niﬁcant early and late mortality (Mair et al., 1976). Their re-
sults, as well as those of others, have shown improved early
mortality and considerable relief of symptoms in deeply cya-
notic patients with severe PVOD (Mair et al., 1976; Sagin-Say-
lam and Somerville, 1996). A careful cardiac catheterisation
assessment is essential for determining whether any patient
should be considered for PAS.
Bukhart et al. reported a series of 24 patients with different
pathologies who underwent a PAS. If the patient was only 1 or2 years old and there was a good reduction in PVR with 100%
oxygen inhalation, an atrial switch with VSD closure was con-
sidered. Alternatively, if the patient was older or had a poor
response to 100% oxygen, the authors favoured PAS. If the
VSD was closed in a borderline atrial switch candidate and
the patient’s haemodynamics were suboptimal after weaning
from cardiopulmonary bypass, the bypass was reinstituted
and a hole placed in the VSD patch. Pulmonary vascular resis-
tance less than 8 Woods units m2 may result in an unaccept-
able left-to-right shunt and ventricular failure after PAS. The
authors reported a signiﬁcant improvement in NYHA func-
tional class and a survival rate (54%) after 15 years of fol-
low-up (Burkhart et al., 2004).
The arterial switch procedure has become the operation of
choice during the neonatal period for management of TGA
with or without VSD. Case reports of its application (leaving
the VSD open) in the setting of late presentation pulmonary
hypertension and PVOD exist in the literature (Pridjian
et al., 1992; Elizari and Somerville, 1999). A palliative arterial
switch has some potential advantages over PAS, especially
with respect to avoiding late atrial arrhythmias and bafﬂe
obstruction; however, long-term results in this setting are not
yet available. Both procedures are valid and effective; at the
present time, the decision regarding which surgery to perform
is made according to the individual surgeon’s experience and
preference (Burkhart et al., 2004).
In summary, we report a patient with TGA and a large
VSD with Eisenmenger syndrome who underwent a successful
palliative atrial switch operation with improvement in func-
tional capacity.References
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